|
|
|
| The PDA Pharmaceutical Microbiology Conference 2025 marks two decades of advancing microbiological science and practice. This milestone event brings together the global microbiology community, including experts from industry, academia, and regulatory agencies, to explore the evolving landscape of pharmaceutical microbiology. This year’s theme, Microbial Resilience: Today’s Response, Tomorrow’s Plan, reflects our focus on navigating present-day challenges while building robust strategies for the future. |
|
|
FOCUS ON TRANSLATIONAL RESEARCH |
|
|
|
By Francisco Conesa Buendía | Logic gating applies Boolean logic principles to CAR T cell design to improve precision and minimize collateral damage. | |
|
|
|
| Label-Free Whole-Body Pharmacokinetics | Webinar | Aliri Bioanalysis | This approach enables tissue-level analysis, delivering insights into efficacy at the site of action, uncovering potential safety concerns, and supporting smarter clinical candidate selection. |
|
|
|
| Real-Time PCR And Gene Expression Specificity | Application Note | Applied Biosystems by Thermo Fisher Scientific, qPCR | Gene expression analysis requires high specificity to ensure accurate results. Methods like probe-based assays offer greater specificity than dye-based detection. |
|
|
| Optimized And Scalable LNP Composition For RNA Vaccine Delivery | Poster | By Natalie Orr (Presenting author), Mikayla Walsh, Cayden Yu, Victoria Hartman, et al., Cytiva | Explore results from a study screening novel LNP formulations for physicochemical attributes, in vitro potency, and in vivo immunogenicity in both SARS-CoV-2 and influenza vaccine applications. |
|
|
TRANSLATIONAL RESEARCH SOLUTIONS |
|
|
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
| Connect With Cell & Gene: |
|
|
|
